New England Cannabis Convention comes amid federal policy shift

The New England Cannabis Convention is drawing heightened attention this year as the federal government moves forward with reclassifying marijuana from Schedule I to Schedule III. The policy shift has attendees and industry leaders energized about the future of legal cannabis in the region and across the country.

The convention, a staple event for cannabis industry professionals, entrepreneurs, and advocates, comes at a pivotal moment. For decades, the Schedule I classification has created a wall of federal restrictions that made banking difficult, tax burdens punitive, and interstate commerce impossible. Reclassification to Schedule III signals a fundamental shift in how the federal government views cannabis — from a dangerous substance with no medical value to a drug with recognized therapeutic applications.

Convention attendees are weighing in on both the opportunities and the uncertainties. The tax relief from removing Section 280E restrictions tops the list of benefits, but questions remain about timing, state-federal regulatory conflicts, and how reclassification will affect existing state markets that have already built frameworks under Schedule I.

New England has been a patchwork of cannabis policy. Massachusetts and Connecticut have legalized recreational use, while other states in the region operate medical-only programs or maintain stricter prohibitions. Federal reclassification could create pressure on holdout states to ease their own restrictions, potentially opening new markets throughout the Northeast.

Industry leaders at the convention are also discussing the long-term implications for research. Schedule III status is expected to make it easier for scientists to study cannabis, which could lead to FDA-approved cannabis-based medicines and further destigmatization.

What This Means For You: If you're in the cannabis industry or considering entering it, the federal policy shift could be a game-changer for your bottom line and your banking options. Attendees at the convention are already strategizing for the post-reclassification landscape. If you're a patient or consumer in a state with restrictive laws, this change could eventually lead to expanded access. And if you're an entrepreneur, the window to position yourself ahead of the regulatory shift is open now — but it won't stay open forever.